De nobis

In MCMXCIV, Nanyang Tianhua Pharmaceutical Co, Ltd constituta. Hoc est a statu-possessores congressus.

In MMIX, Mr Wang Feng, in Group Praesidem, Nanyang acquiritur Tianhua Pharmaceutical Co, Ltd sunt currently in magis quam CC officinas productio II elit. Est pelagus productio officina, sulfamonomethoxine (sodium) In Sinis, magis quam DC cum annua output de C.

In MMX, Nanyang Libang Pharmaceutical Co, Ltd in acquired.Located Wadian, Wancheng District, Nanyang urbem, in MCMLXXXVI, et illa condita est plus quam CCC elit nunc. Quod maxime facit ut Nicarbazine veterinarii API: premix ut Nicarbazine premix, Tilmicosin premix veterinarii et alterum pendet.

In May 2014, Mr. Wang Feng acquired Shanghai Quanyu Biotechnology Neixiang Pharmaceutical Co., Ltd.and changed its name to Henan Quanyu Pharmaceutical Co., Ltd. Located in Neixiang County, Nanyang City,it is a pharmaceutical enterprise integrating the R&D, production, and sales of pharmaceutical preparations, Chinese traditional medicines, and API. There are more than 600 employees.

Mense autem Aprili anni MMXV, Henan Quanyu Pharmaceutical Co, Ltd ad publica de stirpe (DCCCXXXII)CCV codice.

In May, MMXVI, Nanyang Tianhua Sinica Co, Ltd statutum, quod erat post renamed Nanyang Tianhua Group Co. Biotechnology, in Ltd.Located Longsheng Industrial Park, Wolong District, Nanyang: Hoc est officium coetus oratio in praetorium traxere praefecti.

In MMXVIII, Henan Central Novum Material Co, Ltd posuit up.The project sita in area chemical industria congregatione Anpeng oppidum Tongbai Comitatus, Nanyang urbem, Henan provinciae. Quod maxime facit sulfonamides industriae, dichloropyrimidine, dihydroxypyrimidine, sulfamidine, trimethyl PHOSPHATE, Industrial sodium sal, et in benzofuran.